此页面上的内容需要较新版本的 Adobe Flash Player。

获取 Adobe Flash Player

Home > Media > Company News

DISHA Pharmaceutical Group in Frankfurt, Germany to participate in 2011 World Expo pharmaceutical bulk drugs

2011-11-15

October 25 -28, CPhI exhibition (CPhI Worldwide) in Frankfurt, Germany International Exhibition Centre, Mogadishu Di Su Pharmaceutical Co., Ltd. Pharmaceutical Group delegation to participate in the exhibition.

 

The field of pharmaceutical raw materials as the largest and most influential exhibition, which lasted 19 years CPhI exhibition (CPhI Worldwide) has been a tremendous worldwide influence in the formation of CPhI series of exhibitions (CPhI Japan, CPhI China, CPhI India, CPhI South America) at the same time, CPhI Worldwide continues to occupy an irreplaceable position as the global pharmaceutical industry's annual gathering of raw materials.

 

Mogadishu by the General Manager, Pharmaceutical Group and Vice President Li Zongwen Kut led to attend the exhibition. In the four-day event, Mogadishu Pharmaceutical Group exhibition not only showcases Diesel Group Pharmaceutical Co., Ltd. production of bulk drugs and intermediates, both domestic and foreign counterparts and participants had a full and effective communication, not only to promote the product, more depth and broaden understanding.

 

The exhibition display content: active ingredients, amino acids, antibiotics, antimicrobial preservatives, hormones and synthetic products, capsules, animal and plant extracts, a catalyst, bulk pharmaceutical raw materials, emulsifiers, melting agents, herbal teas, intermediates, fine chemicals , resin, medicinal plants, serum and vaccines, suppositories and tablets, etc.

 

It is understood that the world pharmaceutical bulk drugs from around the world exhibition to attract over 2,000 exhibitors and more than 20,000 decision-making buyers and exhibitors across five continents, Germany, Italy, France, the United States participating companies and commercial companies accounted for 50 %, Asian exhibitors from China, India, Japan, Korea, Singapore, Taiwan, Hong Kong and other 50%.